Actively Recruiting
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
Led by Qinghai Red Cross Hospital · Updated on 2025-03-25
60
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The core objectives of this study are to assess the short-term and long-term efficacy of auricular acupoint pressure beans combined with electroacupuncture and estazolam in the treatment of cancer-caused insomnia. The study aims to accurately compare the differences between this combination therapy and standard Western medicine in improving sleep quality and effectively alleviating anxiety and depression. Additionally, it will meticulously observe the safety of the combined treatment and record the occurrence and potential causative factors of any adverse reactions.
CONDITIONS
Official Title
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 and above.
- Confirmed diagnosis of malignant solid tumor by pathological examination.
- Cancer-caused insomnia symptoms lasting more than 1 month, occurring 3 or more times per week.
- Insomnia Severity Index (ISI) score of 8 or higher and meeting insomnia disorder criteria in DSM-5.
- No use of insomnia-related medications in the last 1 month.
- No serious dysfunction of heart, liver, kidneys, or other vital organs.
- Volunteered for the study and signed informed consent form.
You will not qualify if you...
- Irregular sleep-wake cycles due to shift work or inconsistent schedules.
- Untreated or inadequately treated other sleep disorders such as sleep apnea or restless leg syndrome.
- Received acupuncture or auricular pressure bean therapy within the past 3 months.
- Estimated life expectancy of 3 months or less.
- History of severe allergies to drugs or treatments used in this study.
- History of severe mental illness with a current episode.
- History of substance abuse or alcohol dependence.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China, Qinghai,Qinghai Red Cross Hospital
Xining, Qinghai, China, 810000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here